• 1
    Rosse WF. Paroxysmal nocturnal hemoglobinuria. In: RosseWF, eds. Clinical Immunohematology: Basic Concepts and Clinical Applications. Boston: Blackwell Scientific Publications, 1990:593593.
  • 2
    Parker CJ. Paroxysmal nocturnal hemoglobinuria and complement-mediated red cell damage. Curr Opin Hematol 1994; 1:151156.
  • 3
    Wilcox LA, Ezzell JL, Bemshaw NJ, et al. Molecular basis for the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum. Blood 1991; 78:820829.
  • 4
    Nicholson-Weller A. Decay accelerating factor. Curr Top Microbiol Immunol 1992; 178:730.
  • 5
    Holguin NM, Parker CJ. Membrane inhibitor of reactive lysis. Curr Top Microbiol Immunol 1992; 178:6185.
  • 6
    Lublin DM. Glycosyl-phosphatidylinositol anchoring of membrane proteins. Curr Top Microbiol Immunol 1992; 178:141162.
  • 7
    Rosse WF. The glycolipid anchor of membrane surface proteins. Semin Hematol 1992; 30:219231.
  • 8
    Rosse NW, Ware RE. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood 1995; 86:32773286.
  • 9
    Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993; 73:703711.
  • 10
    Miyata T, Junji T, Iida Y, et al. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 1993; 59:13181320.
  • 11
    Dacie JV, Lewis SM. Paroxysmal nocturnal hemoglobinuria; clinical manifestations, haematology and nature of disease. Ser Haematol 1972; 3:323.
  • 12
    Socie' G, Mary JY, de Gramont A, et al. Long term follow-up and prognostic factors in paroxysmal nocturnal hemoglobinuria (PNH): a study on 203 cases by the French Society of Hematology. Blood 1995; 86(suppl 1):130a.
  • 13
    Yamashina M, Ueda D, Kinoshita T, et al. Inherited complete deficiency of 20 kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1990; 323:11851189.
  • 14
    Rosse WF. Variations in the red cell in paroxysmal nocturnal hemoglobinuria. Br J Haematol 1973; 24:327.
  • 15
    Rosse WF, Dacie JV. Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody. J Clin Invest 1966; 45:736.
  • 16
    Rosse WF. The complement sensitivity of PNH cells. Ser Haematol 1972; 3:101114.
  • 17
    Rosse WF. Paroxysmal nocturnal hemoglobinuria-present status and future prospects. West J Med 1980; 132:219228.
  • 18
    Holguin NM, Wilcox LA, Bemshaw NJ, et al. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 1989; 84:13871394.
  • 19
    Rosse WF, Hall S, Campbell M, et al. The erythrocytes of paroxysmal nocturnal hemoglobinuria of intermediate sensitivity to complement lysis. Br J Haematol 1991; 79:99107.
  • 20
    Endo M, Ware RE, Vreeke TM, et al. Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood 1996 (in press).
  • 21
    Iida Y, Takeda J, Miyata T, et al. Characterization of genomic PIG-A gene: a gene for GPI-anchor biosynthesis and paroxysmal nocturnal hemoglobinuria. Blood 1994; 83:31263131.
  • 22
    Bessler M, Hillmen P, Longo L, et al. Genomic organization of the X-linked gene (PIG-A) that is mutated in paroxysmal nocturnal haemoglobinuria and of a related autosomal pseudogene mapped to 12q21. Hum Mol Genet 1994; 3:751757.
  • 23
    Kawagoe K, Takeda J, Endo Y, et al. Molecular cloning of murine Pig-A, a gene for GPI-anchor biosynthesis, and demonstration of interspecies conservation of its structure, function, and genetic locus. Genomics 1994; 23:566574.
  • 24
    Bessler M, Mason P, Hillmen P, et al. Somatic mutations and cellular selection in paroxysmal nocturnal hemoglobinuria. Lancet 1994; 343:951953.
  • 25
    Yamada N, Miyata T, Maeda K, et al. Somatic mutations of PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 1995; 85:885892.
  • 26
    Nafa K, Mason PJ, Hillmen P, et al. Mutations in PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frame shift type. Blood 1995; 86:46504655.
  • 27
    Ostendorf T, Nischan C, Schubert J, et al. Heterogeneous PIG-A mutations in different cell lineages in paroxysmal nocturnal hemoglobinuria. Blood 1995; 85:16401646.
  • 28
    Nafa K, Bessler M, Mason PJ, et al. The complex nature of somatic mutations in paroxysmal nocturnal hemoglobinuria. Blood 1995; 86(suppl 1):245a.
  • 29
    Oni SB, Osunkoya BO, Luzzatto L. Paroxysmal nocturnal hemoglobinuria: evidence of monoclonal origin of abnormal red cells. Blood 1970; 36:145152.
  • 30
    Josten KM, Tooze JA, Borthwick-Clarke C, et al. Acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria: studies on clonality. Blood 1991; 78:31623167.
  • 31
    Ohashi H, Hotta T, Ichikawa A, et al. Peripheral blood cells are predominantly chimeric of affected and normal cells in patients with paroxysmal nocturnal hemoglobinuria: simultaneous investigation of clonality and expression of glycosylphosphatidylinositol-anchored proteins. Blood 1994; 83:853859.
  • 32
    Endo M, Beatty PG, Vreeke TM, et al. Syngeneic bone marrow transplantation without conditioning in a patient with paroxysmal nocturnal hemoglobinuria: in vivo evidence that the abnormal stem cells have a survival advantage. Blood 1996 (in press).
  • 33
    Ware RE, Rosse WF, Hall SE. Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal hemoglobinuria. Blood 1995; 86:15861589.
  • 34
    Young NS. The problem of clonality in aplastic anemia: Dr. Dameshek's riddle, revisited. Blood 1992; 79:13851392.
  • 35
    Endo M, Ware RE, Vreeke TM, et al. Identification and characterization of an inherited mutation of PIG-A in a patient with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1996 (in press).
  • 36
    Nagarajan S, Brodsky RA, Young NS, et al. Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood 1995; 86:46564661.
  • 37
    Holliday R, Grigg GW. DNA methylation and mutation. Mutat Res 1993; 285:6167.
  • 38
    Hillmen P, Lewis SM, Bessler M, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995; 333:12531258.
  • 39
    de Planque MM, Bacigalupo A, Würsch A, et al. Long-term follow-up of severe aplastic anemia patients treated with antithymocyte globulin. Br J Haematol 1989; 73:121.
  • 40
    Schrezenmeier H, Marin P, Raghavachar A, et al. Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. Br J Haematol 1993; 85:371377.
  • 41
    Tichelli A, Gratwohl A, Würsch A, et al. Late complications in severe aplastic anemia. Br J Haematol 1988; 69:413418.
  • 42
    Doney K, Pepe M, Storb R, et al. Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone. Blood 1992; 79:25662571.
  • 43
    Schubert J, Vogt HG, Zielinska-Skowronek M, et al. Development of glycosylphosphatidylinositol-anchoring defect characteristic for paroxysmal nocturnal hemoglobinuria in patients with aplastic anemia. Blood 1994; 83:23232328.
  • 44
    Griscelli-Bennaceur A, Gluckman D, Scrobohaci ML, et al. Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link. Blood 1995; 85:13541363.
  • 45
    Nissen C, Filipowicz A, Dalle Carbonare V, et al. Subclinical paroxysmal nocturnal hemoglobinuria (PNH) in aplastic anemia (AA): incidence and predictive factors for progression to clinical disease. Blood 1995; 86(suppl 1):130a.
  • 46
    Young NS, Barrett AJ. The treatment of severe acquired aplastic anemia. Blood 1995; 85:33673377.
  • 47
    Tichelli A, Gratwohl A, Nissen C, et al. Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin. Blood 1992; 80:337345.
  • 48
    Maciejewski JP, Sloand E, Sato T, et al. Impaired hematopoiesis in PNH/aplasia is not associated with a selective proliferative defect in the GPI-protein deficient clone. Blood 1995; 86(suppl 1):589a.
  • 49
    Rotoli B, Luzzatto L. Paroxysmal nocturnal hemoglobinuria. Semin Hematol 1989; 26:201207.
  • 50
    Ware RE, Howard TA, Kamitani T, et al. Chromosomal assignment of genes involved in glycosyl-phosphatidylinositol anchor biosynthesis: implications for the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood 1994; 83:37533757.
  • 51
    Hertenstein B, Wagner B, Bunjes D, et al. Emergence of CD52, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-lH for refractory B-cell non-Hodgkin lymphoma. Blood 1995; 86:14871492.
  • 52
    Schrezenmeier H, Merk B, Ilijewa S, et al. Pig-A gene mutations are a necessary but not sufficient prerequisite for the occurrence of glycosylphosphatidylinositol (GPI)-anchor deficient blood cells. Blood 1995; 86(suppl 1):589a.
  • 53
    Robinson PJ. Phosphatidylinositol membrane anchors and T cell activation. Immunol Today 1991; 12:3541.
  • 54
    Stefanova I, Horejsi V, Ansotegui IJ, et al. GPI-anchored cell-surface molecules complexed to protein tyrosine kinases. Science 1991; 254:10161019.
  • 55
    Graham DL, Gastineau DA. Paroxysmal nocturnal hemoglobinuria as a marker for clonal myelopathy. Am J Med 1992; 93:671674.
  • 56
    Crosby WH. Paroxysmal nocturnal hemoglobinuria: a classic description by Paul Strübing in 1882, and a bibliography of the disease. Blood 1951; 6:270284.